Flash Finance

Prevest Denpro Ltd543363Corporate

Medical Equipment & Supplies Latest results: Jun 2026 13 quarters of data
Consolidated Standalone
₹380.20
MCap ₹456 Cr · P/E 21.0
Prevest Denpro Ltd — Stock analysis & AI research Prevest Denpro Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹19 Cr
Sales · Jun 2026
+20.9% YoY
₹7 Cr
Operating Profit · Jun 2026
+27.4% YoY
35.5%
OPM % · Jun 2026
+5.3% YoY
₹6 Cr
Net Profit · Jun 2026
+27.9% YoY
₹4.70
EPS · Jun 2026
+28.1% YoY

📝 Prevest Denpro Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Prevest Denpro Ltd reported revenue of ₹19 crore for the quarter ended June 2026 (Q1 FY27), up 20.9% from ₹16 crore in the same quarter last year, and up 0.7% sequentially over the March 2026 quarter.

Net profit rose 27.9% year-on-year to ₹6 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹4.70.

Operating profit stood at ₹7 crore — an operating margin (OPM) of 35.5%, compared with 33.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Prevest Denpro Ltd posted revenue of ₹72 crore, a growth of 13.9% over FY25, with a net profit of ₹20 crore (up 12.8% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹75 crore with a net profit of ₹22 crore.

Valuation snapshot

At the current price of ₹380.20, 543363 has a market capitalisation of ₹456 crore and a trailing P/E of about 21.0.

Within the Medical Equipment & Supplies industry, it is the 5th-largest of the 13 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 73.60%, foreign institutional investors (FIIs) 0.65%, domestic institutional investors (DIIs) 0.79%, public shareholders 24.94% of Prevest Denpro Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹456 Cr
Current Price ?
₹380.2
P/E ?
21.01below ind
Industry P/E ?
26.90
P/B ?
3.65
P/S ?
6.07
P/FCF ?
35.10
Enterprise Value ?
₹456 Cr
EV/EBITDA ?
17.44
PEG ?
N/A
Earnings Yield ?
5.3%
Dividend Yield ?
0.27%
Profitability & Returns
Sales (TTM) ?
₹75 Cr
OPM ?
34.8%
Profit after tax (TTM) ?
₹22 Cr
EPS (TTM) ?
₹18.10
ROCE ?
24.0%
ROE ?
17.4%
ROA ?
16.3%
Growth
Sales — latest qtr ?
₹19 Cr
PAT — latest qtr ?
₹6 Cr
YoY qtr sales growth ?
20.9%
YoY qtr profit growth ?
27.9%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
73.60%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-2.8%
Return 6 months ?
0.3%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 13131416131615181619181919 +20.9% +0.7%
Operating Profit 5446565757677 +27.4% -2.1%
Other Income 1111111111111 +12.4% -6.7%
Interest 000000000000— — —
Depreciation 0000000000111 +6.6% +2.5%
Profit Before Tax 5556566767688 +26.2% -3.2%
Net Profit 4445455546566 +27.9% -3.1%
EPS 3.403.033.033.973.064.023.774.283.674.623.934.854.70 +28.1% -3.1%
OPM % 37.0% 33.5% 32.9% 36.9% 33.8% 35.7% 34.8% 35.4% 33.7% 35.8% 31.4% 36.5% 35.5% +5.3% -2.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹63 Cr ₹72 Cr ₹75 Cr +13.9%
Operating Profit ₹22 Cr ₹25 Cr ₹26 Cr +11.9%
OPM % 35.03% 34.40% 34.82% -1.8%
NPM % 28.81% 28.53% 28.92% -1.0%
Other Income ₹4 Cr ₹5 Cr ₹5 Cr +20.9%
Depreciation ₹2 Cr ₹2 Cr ₹2 Cr +5.8%
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹20 Cr ₹23 Cr ₹24 Cr +12.4%
PBT ₹24 Cr ₹28 Cr ₹29 Cr +13.9%
Tax — — ₹2 Cr —
Net Profit ₹18 Cr ₹20 Cr ₹22 Cr +12.8%
EPS ₹15.13 ₹17.07 ₹18.10 +12.8%
Material Cost — — ₹5 Cr —
Employee Cost — — ₹4 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 121212 +0.0%
Reserves 7794113 +20.2%
Borrowings 000 —
Other Liabilities 678 +14.3%
Total Liabilities 95113133 +17.7%
Fixed Assets 272727 +0.0%
CWIP 000 —
Investments 259 +80.0%
Other Assets 668198 +21.0%
Total Assets 95113133 +17.7%

💧 Cash Flow (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 121515 +0.0%
Cash from Investing Activity -2-1-2 -100.0%
Cash from Financing Activity -0-1-1 +0.0%
Net Cash Flow 101212 +0.0%
Free Cash Flow 81313 +0.0%
CFO/OP 81%93%87% -6.5%

➗ Ratios (latest 3 periods)

Metric Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 534444 +0.0%
Inventory Days 168240239 -0.4%
Days Payable 324855 +14.6%
Cash Conversion Cycle 189236229 -3.0%
Working Capital Days 7982135 +64.6%
ROCE % —25%24% -4.0%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 73.60%73.60%73.60%73.60% +0.0%
FIIs 0.63%0.65%0.65%0.65% +0.0%
DIIs 0.75%0.77%0.77%0.79% +2.6%
Public 25.01%24.97%24.97%24.94% -0.1%
No. of Shareholders 1,8881,9571,9601,975 +0.8%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 FISCHER Fischer Medical ₹33.50 2,293 85.2 367 24 12.3% 6.7% 178.6% 2051.4% 249.4% -24.3%
2 TARSONS Tarsons Products ₹330.00 1,756 157.9 441 11 27.0% 2.5% -66.3% -81.4% 20.7% -181.0%
3 DENTALKART Vasa Denticity ₹563.10 977 80.0 299 12 4.4% 4.0% 16.7% -28.5% 12.9% -2.9%
4 543916 Hemant Surgical ₹193.85 544 13.9 231 18 10.4% 7.8% — — 187.9% 160.0%
5 543363 Prevest Denpro ₹616.50 456 32.8 75 23 35.7% 29.9% 13.6% 17.6% 23.7% 24.8%
6 QMSMEDI QMS Medical ₹185.89 359 52.7 162 7 13.1% 4.1% 5.1% -47.9% 23.7% -0.8%
7 NURECA Nureca ₹331.55 331 75.9 153 4 2.7% 2.8% 34.0% 146.7% 18.0% 277.2%
8 530427 Choksi Asia ₹65.64 122 7.2 47 5 14.5% 11.1% 61.1% 173.2% -22.5% -10.1%
9 527005 Shree Pacetronix ₹168.25 55 19.2 21 3 24.8% 15.3% 28.7% 324.3% -8.3% 14.5%
10 544143 Royal Sense ₹139.00 47 24.7 38 3 12.8% 8.0% — — 2.5% -5.4%
11 533212 GKB Ophthalmics ₹104.90 32 17.6 150 6 7.0% 3.7% 36.8% 142.7% 2.3% 388.5%
12 531380 Centenial Surgical ₹110.90 27 — 56 -1 10.7% -2.6% 0.6% -38.1% 18.6% 1937.8%
13 542765 Transpact Enterprises ₹325.00 4 140.1 0 0 63.2% 47.4% — — 12.5% -20.0%
❓ Frequently asked questions
What was Prevest Denpro Ltd's revenue in Q1 FY27?
Prevest Denpro Ltd reported revenue of ₹19 crore for the quarter ended June 2026 (Q1 FY27), up 20.9% from ₹16 crore in the same quarter last year, and up 0.7% sequentially over the March 2026 quarter.
What was Prevest Denpro Ltd's net profit in Q1 FY27?
Net profit rose 27.9% year-on-year to ₹6 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹4.70.
What is 543363's market capitalisation and P/E ratio?
At the current price of ₹380.20, 543363 has a market capitalisation of ₹456 crore and a trailing P/E of about 21.0.
Who owns Prevest Denpro Ltd? (shareholding pattern)
As of Jun 2026, promoters held 73.60%, foreign institutional investors (FIIs) 0.65%, domestic institutional investors (DIIs) 0.79%, public shareholders 24.94% of Prevest Denpro Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI